Showing results (51-60 of 118) with videos related to

Sort By:
Pageof 12
Disease Markers|June 14, 2016
Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary FibrosisKosuke Hamai, Hiroshi Iwamoto, Nobuhisa Ishikawa, et al.
Stem Cell Research & Therapy|August 24, 2021
Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activityHiroshi Takahashi, Taku Nakashima, Takeshi Masuda, et al.
Respiratory Medicine|September 10, 2020
Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung diseaseSatoshi Nakao, Kakuhiro Yamaguchi, Hiroshi Iwamoto, et al.
Cancer Chemotherapy and Pharmacology|August 5, 2021
Association between glucose intolerance and chemotherapy-induced lung injury in patients with lung cancer and interstitial lung diseaseToshihito Otani, Kakuhiro Yamaguchi, Satoshi Nakao, et al.
Respiratory Medicine|April 1, 2023
Serum and bronchoalveolar lavage fluid levels of soluble B7H3 in patients with interstitial lung diseasesTaku Nakashima, Keitaro Omori, Masashi Namba, et al.
Internal Medicine (Tokyo, Japan)|March 7, 2022
Pneumonia and Meningoencephalitis Due to Varicella-zoster Virus Reinfection and Epstein-Barr Virus Reactivation in a Patient with Rheumatoid ArthritisNoriaki Ito, Takeshi Masuda, Kakuhiro Yamaguchi, et al.
American Journal of Clinical Pathology|March 26, 2021
Analysis of microRNA Expression in Liquid-Based Cytology Samples May Be Useful for Primary Lung Cancer DiagnosisYusuke Araki, Koji Arihiro, Kakuhiro Yamaguchi, et al.
The Clinical Respiratory Journal|August 30, 2020
Correlations of forced oscillometric bronchodilator response with airway inflammation and disease duration in asthmaNaoko Higaki, Hiroshi Iwamoto, Kakuhiro Yamaguchi, et al.
Internal Medicine (Tokyo, Japan)|October 1, 2020
Alectinib-induced Immune Hemolytic Anemia in a Patient with Lung AdenocarcinomaJoe Okumoto, Shinjiro Sakamoto, Takeshi Masuda, et al.
Cancers|February 26, 2025
Predictive Value of Circulatory Total VEGF-A and VEGF-A Isoforms for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small-Cell Lung CancerTetsu Hirakawa, Kakuhiro Yamaguchi, Kunihiko Funaishi, et al.
Pageof 12